1) Prednisolone Sodium Phosphate
泼尼松龙磷酸钠
2) prednisolone sodium phosphate
氢化泼尼松磷酸钠
3) Prednisolone
[英][pred'nisələun] [美][prɛd'nɪsə,lon]
醋酸泼尼松龙
1.
Transtympanic Prednisolone Treatment for Subjective Tinnitus;
鼓室内灌注醋酸泼尼松龙治疗主观性耳鸣的临床观察
2.
Transtympanic Prednisolone Treatment for Idiopathic Sudden Sensorineural Hearing Loss;
鼓室内灌注醋酸泼尼松龙治疗突发性聋的初步观察
3.
Male rats were treated with prednisolone acetate(5mg/kg/day,2 days/week) for 12 weeks and the osteoporosis condition on 8th,12th week during injection and 8th,11th and 14th week since the injection was stopped were measured by BMD,biomechanical properties and bone histomorphometric parameters.
雄性大鼠肌肉注射醋酸泼尼松龙5mg/kg/次,每周2次,12周后停止注射,继续观察14周,用骨密度、骨生物力学指标和骨组织计量学等三方面的指标对造模8周、12周及停止注射糖皮质激素8周、11周和14周的骨质疏松状况作综合评价。
4) Prednisolone acetate
醋酸泼尼松龙
1.
Concurrent Determination of Chloramphenicol and Prednisolone Acetate in Chloramphenicol and Prednisolone Acetate Eye Drops by HPLC;
HPLC法同时测定氯霉素醋酸泼尼松龙滴眼液中两组分含量
2.
Preparation of prednisolone acetate lipid nanoparticles;
醋酸泼尼松龙脂质纳米球的制备
3.
Preparation of inclusion complex of prednisolone acetate and β-cyclodextrin;
醋酸泼尼松龙β-环糊精包合物的研制
5) 17-Valerate 21-acetate prednisolone
泼尼松龙戊酸酯
6) prednisolone
[英][pred'nisələun] [美][prɛd'nɪsə,lon]
泼尼松龙
1.
Preparation of prednisolone micro-powders by spray drying;
喷雾干燥法制备泼尼松龙微粉
2.
Comparison of the efficacy of nebulised budesonide with oral prednisolone in treatment of acute exacerbations of chronic obstructive pulmonary disease;
布地奈德雾化和口服泼尼松龙治疗COPD急性加重期的疗效比较
3.
Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats;
泼尼松龙新型靶向脂质体制剂对嘌呤霉素氨基核苷肾病的疗效
补充资料：泼尼松龙磷酸钠
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条